Results 121 to 130 of about 44,626 (291)
ABSTRACT Objective To analyse sex differences in health‐related quality of life (HRQL) before, during and up to 3 months posttreatment of head and neck cancer, and to examine the importance of salivary secretion rate for HRQL posttreatment. Methods Patients were recruited before starting curative oncologic treatment.
Niklas Bohm +4 more
wiley +1 more source
Spinal diffuse midline glioma: An unusual case presentation
Primary spinal cord neoplasms are rare, accounting for 1% of paediatric central nervous system tumours. The majority of which are low-grade gliomas (LGG). A teenage male presented with rapidly progressive lower limb paralysis. He subsequently underwent a
Nadia Beringer +14 more
doaj +1 more source
Objectives To obtain insights for establishing radiation therapy strategies that provide long‐term locoregional benefits in canine apocrine gland anal sac adenocarcinoma, we evaluated whether a dose‐escalated protocol (10 × 4.0 Gy) could improve clinical outcomes, particularly long‐term locoregional control, while maintaining acceptable toxicity ...
M. Terauchi +3 more
wiley +1 more source
ABSTRACT Objective Head and neck cancer radiotherapy can lead to jaw osteoradionecrosis (ORN). There is currently no definitive treatment for ORN. The efficacy of a novel orally delivered aglycosylated IGF‐1 with an E‐peptide (CTB‐Pro‐IGF‐1), bioencapsulated in plant cells, was evaluated as therapy for jaw ORN in rats. Materials and Methods Rat jaw ORN
Sunday O. Akintoye +5 more
wiley +1 more source
Aim : To evaluate the integral dose to carotid vessels in extended field intensity modulated radiotherapy (IMRT) (including the lower neck nodes in IMRT field) and split field IMRT (using separate single anterior field to treat lower neck nodes) in ...
Thulkar, S. +5 more
core +2 more sources
Background: Regardless of primary malignancy, whole-brain radiation therapy (WBRT) is the preferred treatment for brain metastases. However, WBRT exposes the parotid glands to significant radiation.
RA Sunil +5 more
doaj +1 more source
ABSTRACT Gilvetmab is a caninised monoclonal antibody against canine PD‐1. Concurrent or sequential administration of anti‐PD‐1 antibodies and radiation therapy (RT) improves survival time in various species. Eighteen dogs with mast cell tumours (MCTs) were prospectively treated with 24 Gy of RT over Days 0, 7 and 21 and gilvetmab every 2 weeks ...
Tiffany W. Martin +2 more
wiley +1 more source
Radiation‐Induced Alopecia in Dogs With Nasal Tumours: Coat Type Influences Development and Onset
Background: Radiation‐induced alopecia (RIA) is a common adverse effect of radiation therapy, yet factors influencing its development in dogs remain unclear. Objectives: To characterise acute RIA in dogs with nasal tumours and to evaluate associations with coat type and radiation dose.
Yuki Nemoto +4 more
wiley +1 more source
Meng Xu, Chang Liu, Jing Lin Mi, Ren Sheng Wang Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Radiation Oncology Clinical Medical Research Center of Guangxi, Nanning 530021, Guangxi, People’s ...
Xu M, Liu C, Mi JL, Wang RS
doaj
Dosimetric evaluation of nasopharyngeal carcinomas irradiated with different IMRT techniques
Purpose: To evaluate the performance of volumetric arc therapy (VMAT), dynamic intensity modulated radiotherapy (IMRT) and step-and-shoot IMRT techniques in nasopharyngeal cancer (NPC) patients.
Onay, Ozgehan +7 more
core

